Skip to main content
SpringerLink
Log in

Cost-Effective Management of Diabetic Foot Ulcers

A Review

  • Review Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

Foot lesions are common and serious complications in patients with diabetes mellitus. In recent years, several authors have, in addition to the medical aspects, focused on the high costs for treatment of this complication. However, few studies have performed a complete health-economic comparison and analysis of different treatments. This is probably related to the complexity of the problem and ethical difficulties in performing randomised clinical trials on these patients.

Despite the lack of comparative health-economic studies, most authors conclude that amputations should be avoided if there is any possibility of saving the limb. This is not only because of the economic consequences — high costs for repeated hospitalisations, rehabilitation, home care and social-service support—associated with amputations, but also the quality-of-life aspects. Alternative treatment options might seem costly in the short term, but most cost-effectiveness analyses that also consider the long term perspective have concluded that treatment alternatives in which the limb is saved are more cost effective.

Methodological aspects, such as the perspective of a study, may cause difficulties in comparing results between countries and settings. By using the societal perspective in economic studies, incentives to push costs from one sector to another might be avoided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jonsson B. Diabetes — the cost of illness and the cost of control: an estimate for Sweden 1978. Acta Med Scand 1983; Suppl. 671: 19–27

    CAS  Google Scholar 

  2. Apelqvist J, Ragnarson-Tennvall G, Persson U, et al. Diabetic foot ulcers in a multidisciplinary setting: an economic analysis of primary healing and healing with amputation. J Intern Med 1994; 235: 463–71

    Article  PubMed  CAS  Google Scholar 

  3. Fylling CP, Knighton DR. Amputation in the diabetic population: incidence, causes, cost, treatment, and prevention. J Enterostomal Ther 1989; 16: 247–55

    PubMed  CAS  Google Scholar 

  4. Reiber GE. Diabetic foot care: financial implications and practice guidelines. Diabetes Care 1992; 15 Suppl. 1: 29–31

    PubMed  Google Scholar 

  5. Mackey WC, McCullough JL, Conlon TP, et al. The cost of surgery for limb-threatening ischemia. Surgery 1986; 99: 26–35

    PubMed  CAS  Google Scholar 

  6. Solomon C, van Rij AM, Barnett R, et al. Amputations in the surgical budget. N Z Med J 1994; 107: 78–80

    PubMed  CAS  Google Scholar 

  7. Waugh NR. Amputations in diabetic patients: a review of rates, relative risks and resource use. Community Med 1988; 10 (4): 279–88

    PubMed  CAS  Google Scholar 

  8. Borssen B, Bergenheim T, Lithner F. The epidemiology of foot lesions in diabetic patients age 15–50 years. Diabet Med 1990; 7: 438–44

    Article  PubMed  CAS  Google Scholar 

  9. Evans SL, Nixon BP, Lee I, et al. The prevalence and nature of podiatric problems in elderly diabetic patients. J Am Geriatr Soc 1991; 39: 241–5

    PubMed  CAS  Google Scholar 

  10. Neil HA, Thompson AV, Thorogood M, et al. Diabetes in the elderly: the Oxford community study. Diabet Med 1989; 6: 608–13

    Article  PubMed  CAS  Google Scholar 

  11. Reenders K, de Nobel E, van den Hoogen HJM, et al. Diabetes and its long term complications in general practice: a survey in a well defined population. Fam Pract 1993; 10: 169–72

    Article  PubMed  CAS  Google Scholar 

  12. Walters DP, Gatling W, Mullee MA, et al. The distribution and severity of diabetic foot disease: a community study with comparison to a non-diabetic group. Diabet Med 1992; 9: 354–8

    Article  PubMed  CAS  Google Scholar 

  13. Larsson J, Apelqvist J, Agardh CD, et al. Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabet Med 1995; 12: 770–6

    Article  PubMed  CAS  Google Scholar 

  14. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990; 13 (5): 513–21

    Article  PubMed  CAS  Google Scholar 

  15. Deerochanawong C, Home PD, Alberti KGMM. A survey of lower-limb amputation in diabetic patients. Diabet Med 1992; 9: 942–6

    Article  PubMed  CAS  Google Scholar 

  16. Delbridge L, Appelberg M, Reeve TS. Factors associated with development of foot lesions in the diabetic. Surgery 1983; 93: 78–82

    PubMed  CAS  Google Scholar 

  17. Delbridge L, Ctercteko G, Fowler C, et al. The aetiology of diabetic neuropathic ulceration of the foot. Br J Surg 1985; 72: 1–6

    Article  PubMed  CAS  Google Scholar 

  18. Boulton AJM, Kubrusly DB, Bowker JH, et al. Impaired vibratory perception and diabetic foot ulceration. Diabet Med 1986; 3: 335–7

    Article  PubMed  CAS  Google Scholar 

  19. Edmonds ME. The diabetic foot: pathophysiology and treatment. Baill Clin Endocrinol Metab 1986; 15: 889–916

    Article  CAS  Google Scholar 

  20. Boulton AJM. The diabetic foot. Med Clin North Am 1988; 72 (6): 1513–30

    PubMed  CAS  Google Scholar 

  21. Sims DS, Cavanagh PR, Ulbrecht JS. Risk factors in the diabetic foot: recognition and management. Phys Ther 1988; 68 (12): 1887–901

    PubMed  Google Scholar 

  22. Apelqvist J, Larsson J, Agardh C-D. The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers. J Diabetes Complications 1990; 4: 21–5

    Article  CAS  Google Scholar 

  23. Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in primary health care setting. Diabetes Care 1992; 1 (10): 1385–9

    Google Scholar 

  24. Larsson J, Apelqvist J, Agardh C-D, et al. Local signs and symptoms in relation to final amputation level in diabetic patients. Acta Orthop Scand 1994; 65 (4): 387–93

    Article  PubMed  CAS  Google Scholar 

  25. Edmonds ME, Blundell MP, Morris ME, et al. Improved survival of the diabetic foot: the role of a specialised foot clinic. Q J Med 1986; New Series 60: 763–71

    Google Scholar 

  26. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus: a case-control study. Ann Intern Med 1992; 117 (2): 97–105

    PubMed  CAS  Google Scholar 

  27. World Health Organization/IDF. Diabetes care and research in Europe: the St Vincent Declaration. Diabet Med 1990; 7: 360

    Article  Google Scholar 

  28. Lithner F. Cutaneous erythema, with or without necrosis, localized to the legs and feet: a lesion in elderly diabetics. Acta Med Scand 1974; 196: 333–42

    Article  PubMed  CAS  Google Scholar 

  29. Lithner F, Tornblom N. Gangrene localized to the feet in diabetic patients. Acta Med Scand 1984; 215: 75–9

    Article  PubMed  CAS  Google Scholar 

  30. Bild DE, Selby JV, Sinnock P, et al. Lower-extremity amputation in people with diabetes: epidemiology and prevention. Diabetes Care 1989; 1 (1): 24–31

    Article  Google Scholar 

  31. Apelqvist J, Castenfors J, Larsson J, et al. Prognostic value of systolic ankle and toe blood pressure levels in outcome of diabetic foot ulcer. Diabetes Care 1989; 12 (6): 373–8

    Article  PubMed  CAS  Google Scholar 

  32. Apelqvist J, Castenfors J, Larsson J, et al. Wound classification is more important than site of ulceration in the outcome of diabetic foot ulcers. Diabet Med 1989; 6: 526–30

    Article  PubMed  CAS  Google Scholar 

  33. Apelqvist J, Larsson J, Agardh C-D. The importance of peripheral pulses, peripheral oedema and local pain for the outcome of diabetic foot ulcers. Diabet Med 1990; 7: 590–4

    Article  PubMed  CAS  Google Scholar 

  34. Apelqvist J, Larsson J, Agardh C-C. Medical risk factors in diabetic patients with foot ulcers and severe peripheral vascular disease and their influence on outcome. J Diabetes Complications 1992; 6: 167–74

    Article  PubMed  CAS  Google Scholar 

  35. Frykberg RG, editor. The high-risk foot in diabetes mellitus. London: Churchill Livingstone, 1991

  36. Apelqvist J, Agardh C-D. The association between clinical risk factors and outcome of diabetic foot ulcers. Diabetes Res Clin Pract 1992; 18: 43–53

    Article  PubMed  CAS  Google Scholar 

  37. Levin ME, O’Neal LW, Bowker JH, editors. The diabetic foot. 5th ed. St. Louis (MO): Mosby Year Book, 1993

  38. Drummond MF, Stoddard GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford Medical Publications, 1990

    Google Scholar 

  39. Koopmanschap MA. Rutten FFH. Indirect costs in economic studies: confronting the confusion. Pharmacoeconomics 1993; 4: 446–54

    Article  PubMed  CAS  Google Scholar 

  40. Drummond M. Cost-of-illness studies: a major headache? Pharmacoeconomics 1992; 2: 1–4

    Article  PubMed  CAS  Google Scholar 

  41. Apelqvist J, Ragnarson-Tennvall G, Larsson J. Topical treatment of diabetic foot ulcers: an economic analysis of treatment alternatives and strategies. Diabet Med 1995; 12: 123–8

    Article  PubMed  CAS  Google Scholar 

  42. Apelqvist J, Ragnarson-Tennvall G, Larsson J, et al. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int 1995; 16: 388–94

    PubMed  CAS  Google Scholar 

  43. Apelqvist J, Ragnarson-Tennvall G. Cavity foot ulcers in diabetic patients — a comparative study of cadexomer iodine ointment and standard treatment: an economic analysis alongside a clinical trial. Acta Derm Venereol 1996; 76: 231–6

    PubMed  CAS  Google Scholar 

  44. Eckman MH, Greenfield S, Mackey WC, et al. Foot infections in diabetic patients: decision and cost-effectiveness analyses. JAMA 1995; 273: 712–20

    Article  PubMed  CAS  Google Scholar 

  45. Levin ME. Preventing amputation in the patient with diabetes. Diabetes Care 1995; 18: 1383–94

    PubMed  CAS  Google Scholar 

  46. Raviola CA, Nichter LS, Baker JD, et al. Cost of treating advanced leg ischemia: bypass graft vs primary amputation. Arch Surg 1988; 123: 495–6

    Article  PubMed  CAS  Google Scholar 

  47. Gupta SK, Veith FJ, Ascer E, et al. Cost factors in limb-threatening ischaemia due to infrainguinal arteriosclerosis. Eur J Vase Surg 1988; 2: 151–4

    Article  CAS  Google Scholar 

  48. Gibbons GW, Marcaccio Jr EJ, Burgess AM, et al. Improved quality of diabetic foot care, 1984 vs 1990: reduced length of stay and costs, insufficient reimbursement. Arch Surg 1993; 128: 576–81

    Article  PubMed  CAS  Google Scholar 

  49. Hansen ST. Overview of the severely traumatized lower limb. Clin Orthop 1989; 243: 17–9

    PubMed  Google Scholar 

  50. LoGerfo FW, Gibbons GW, Pomposelli Jr FB, et al. Trends in the care of diabetic foot: expanded role of arterial reconstruction. Arch Surg 1992; 127: 617–21

    Article  PubMed  CAS  Google Scholar 

  51. Holstein P, Ellitsgaard N, Sørensen S, et al. The number of amputations has decreased [in Danish]. Nord Med 1996; 111 (5): 142–4, 160

    PubMed  CAS  Google Scholar 

  52. Cheshire NJW, Wolfe JHN, Noone MA, et al. The economics of femorocrural reconstruction for critical leg ischemia with and without autologous vein. J Vase Surg 1992; 15: 167–75

    Article  CAS  Google Scholar 

  53. Cheshire NJW, Noone MA, Wolfe JHN. Re-intervention after vascular surgery for critical leg ischaemia. Eur J Vase Surg 1992; 6: 545–50

    Article  CAS  Google Scholar 

  54. Johnson BF, Evans L, Drury R, et al. Surgery for limb threatening ischaemia: a reappraisal of the costs and benefits. Eur J Vase Endovasc Surg 1995; 9: 181–8

    Article  CAS  Google Scholar 

  55. Callow AD, Mackey WC. Costs and benefits of prosthetic vascular surgery. Int Surg 1988; 73: 237–240

    PubMed  CAS  Google Scholar 

  56. SBU, The Swedish Council on Technology Assessment in Health Care. Karlkirurgi vid aderforkalkning i benen. Stockholm: SBU, 1990

    Google Scholar 

  57. Knighton DR, Fylling CP, Fiegel VD, et al. Amputation prevention in an independently reviewed at-risk diabetic population using a comprehensive wound care protocol. Am J Surg 1990; 160: 466–71

    Article  PubMed  CAS  Google Scholar 

  58. Bruijnen H, Loeprecht H. Cost-benefit analysis of limb salvage [in German]. Langenbecks Arch Chir 1989; Suppl. II: 617–9

    Google Scholar 

  59. Davies L, Noone M, Drummond M, et al. Technology assessment in the development of guidelines for vascularising the ischaemic leg. York: University of York, 1991

    Google Scholar 

  60. Taylor Jr LM, Porter JM. The clinical course of diabetics who require emergent foot surgery because of infection or ischemia. J Vase Surg 1987; 6: 454–9

    Google Scholar 

  61. West NJ. Systemic antimicrobial treatment of foot infections in diabetic patients. Am J Health Syst Pharm 1995; 52: 1199–207

    PubMed  CAS  Google Scholar 

  62. Criado E, De Stefano AA, Keagy BA, et al. The course of severe foot infection in patients with diabetes. Surg Gynecol Obstet 1992; 175: 135–40

    PubMed  CAS  Google Scholar 

  63. Benton GS, Kerstein MD. Cost effectiveness of early digit amputation in the patient with diabetes. Surg Gynecol Obstet 1985; 161: 523–4

    PubMed  CAS  Google Scholar 

  64. Beltran J, Campanini DS, Knight C. The diabetic foot: magnetic resonance imaging evaluation. Skeletal Radiol 1990; 19: 37–41

    Article  PubMed  CAS  Google Scholar 

  65. Weinstein D, Wang A, Chambers R, et al. Evaluation of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. Foot Ankle Int 1993; 14: 18–22

    CAS  Google Scholar 

  66. Morrison WB, Schweitzer ME, Wapner KL, et al. Osteomyelitis in feet of diabetics: clinical accuracy, surgical utility, and cost-effectiveness of MR imaging. Radiology 1995; 196: 557–64

    PubMed  CAS  Google Scholar 

  67. Thomas S. Cost-effective management of leg ulcers. Community Outlook 1990; March: 21–2

    Google Scholar 

  68. Lindholm C. Results of cost-effectiveness aspects in leg ulcer clinical trials. Proceedings of the 4th Annual Meeting of the European Tissue Repair Society on Cost-Effectiveness of Wound Treatments; 1994 Aug 26: Oxford, England. Cambridge: Beiersdorf AG and Perstorp Pharma, 1994: 5.1–16

    Google Scholar 

  69. Bentkover JD, Champion AH. Economic evaluation of alternative methods of treatment for diabetic foot ulcer patients: cost-effectiveness of platelet releasate and wound care clinics. Wounds 1993; 5: 207–15

    Google Scholar 

  70. Larsson J, Apelqvist J. Towards less amputations in diabetic patients: incidence, causes, cost, treatment, and prevention — a review. Acta Orthop Scand 1995; 66: 181–92

    Article  PubMed  CAS  Google Scholar 

  71. Assal J-Ph, Albeanu A, Peter-Riesch B, et al. Cuot de la formation du patient atteint d’un diabete sucre: effets sur la prevention des amputations. Diabete Metab 1993; 19: 491–5

    PubMed  CAS  Google Scholar 

  72. Falkenberg M. Metabolic control and amputations among diaetics in primary health care: a population-based intensified programme governed by patient education. Scand J Prim Health Care 1990; 8: 25–9

    Article  PubMed  CAS  Google Scholar 

  73. Assal J-P. Cost-effectiveness of diabetes education. Pharmacoeconomics 1995; 8 Suppl. 1: 68–71

    Article  Google Scholar 

  74. Pieber TR, Holler A, Siebenhofer A, et al. Evaluation of a structured teaching and treatment programme for type 2 diabetes in general practice in a rural area of Austria. Diab Med 1995; 12: 349–54

    Article  CAS  Google Scholar 

  75. Litzelman DK, Slemenda CW, Langefeld CD, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1993; 119: 36–41

    PubMed  CAS  Google Scholar 

  76. Uccioli L, Faglia E, Monticone G, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995; 18: 1376–8

    Article  PubMed  CAS  Google Scholar 

  77. Breuer U. Diabetic patient’s compliance with bespoke footwear after healing of neuropathic foot ulcers. Diabete Metab 1994; 20: 415–9

    PubMed  CAS  Google Scholar 

  78. Litzelman DK, Marriott DJ, Vinicor F. The role of footwear in the prevention of foot lesions in patients with NIDDM. Conventional wisdom or evidence-based practice? Diabetes Care 1997; 20: 156–62

    Article  PubMed  CAS  Google Scholar 

  79. Apelqvist J, Larsson J, Agardh C-D. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993; 233: 485–91

    Article  PubMed  CAS  Google Scholar 

  80. Clark CM, Kinney ED. Standards for the care of diabetes: origins, uses, and implications for third-party payment. Diabetes Care 1992; 15 Suppl. 1: 10–4

    PubMed  Google Scholar 

  81. Rubin RJ, Altman WA, Mendelson DN. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 1994; 78: 809A–F

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Swedish Institute for Health Economics (IHE), Råbygatan 2, Box 2127, S-220 02, Lund, Sweden

    Gunnel Ragnarson-Tennvall

  2. Department of Internal Medicine, University Hospital of Lund, Lund, Sweden

    Jan Apelqvist

Authors
  1. Gunnel Ragnarson-Tennvall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jan Apelqvist
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gunnel Ragnarson-Tennvall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ragnarson-Tennvall, G., Apelqvist, J. Cost-Effective Management of Diabetic Foot Ulcers. Pharmacoeconomics 12, 42–53 (1997). https://doi.org/10.2165/00019053-199712010-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199712010-00005

Keywords

Search

Navigation